journal article·2024-02Open access

Dual‐Functional Injectable Hydrogel for Osteoarthritis Treatments

Lei Lei, Rui Cong, Yifei Ni, Xin Cui, Xulei Wang, Hongmei Ren, Zun Wang, Mengyuan Liu, Jiasheng Tu, Lei Jiang

Advanced Healthcare Materials· Volume 13· Issue 5

Abstract

Abstract Osteoarthritis (OA) is a prevalent, chronic degenerative disease that affects people worldwide. It is characterized by the destruction of cartilage and inflammatory reactions. High levels of reactive oxygen species (ROS) cause oxidative stress, which damages lipids, proteins, and DNA, leading to cell damage and death. Furthermore, ROS also induces the production of inflammatory cytokines and cell chemotaxis, further worsening the inflammatory response and damaging cartilage resulted in limited movement. Herein, this work reports a dual‐functional injectable hydrogel, which can help inhibit inflammation by scavenging ROS and provide lubrication to reduce wear and tear on the joints. To create the hydrogel, 3‐aminophenylboronic acid modified hyaluronic acid is synthesized, then which is crosslinked with hydroxyl‐containing polyvinyl alcohol (PVA) to construct a dual dynamic covalent crosslinked hydrogel oHA‐PBA‐PVA gel, Gel (HPP). The hydrogel mentioned here possesses a unique bond structure that allows it to be injected, self‐heal, and provide lubrication. This innovative approach offers a new possibility for treating osteoarthritis by combining anti‐inflammatory and lubrication effects.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Proteoglycans and glycosaminoglycans research · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients and Department of Pharmaceutics School of Pharmacy China Pharmaceutical University 24 Tong Jia Xiang Nanjing 210009 China

Funding

National Natural Science Foundation of China

References (55)

Show source-provided references
1. 10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
2. 10.1021/acsnano.3c0178910.1021/acsnano.3c01789 ↗
3. 10.1002/art.3969210.1002/art.39692 ↗
4. 10.1002/smll.20220692910.1002/smll.202206929 ↗
5. 10.1038/s41551-021-00780-310.1038/s41551-021-00780-3 ↗
6. 10.3390/pharmaceutics1412263910.3390/pharmaceutics14122639 ↗
7. 10.1016/j.addr.2020.10.01210.1016/j.addr.2020.10.012 ↗
8. 10.1016/j.freeradbiomed.2020.04.00810.1016/j.freeradbiomed.2020.04.008 ↗
9. 10.1016/j.ccr.2020.21358110.1016/j.ccr.2020.213581 ↗
10. 10.1016/j.mtnano.2022.10024010.1016/j.mtnano.2022.100240 ↗
11. 10.1002/adhm.20220152410.1002/adhm.202201524 ↗
12. 10.1016/j.cej.2021.12928410.1016/j.cej.2021.129284 ↗
13. 10.1016/j.cej.2021.13006610.1016/j.cej.2021.130066 ↗
14. 10.1039/D1TB00728A10.1039/D1TB00728A ↗
15. 10.1038/nchembio.8510.1038/nchembio.85 ↗
16. 10.1016/j.freeradbiomed.2006.05.01110.1016/j.freeradbiomed.2006.05.011 ↗
17. 10.7150/thno.8785410.7150/thno.87854 ↗
18. 10.1002/admi.20200063210.1002/admi.202000632 ↗
19. 10.1038/s41467-020-17242-010.1038/s41467-020-17242-0 ↗
20. Zhang Z. Y. · Adv. Healthcare Mater. · 2023 · 12
21. 10.1021/acsami.2c1270310.1021/acsami.2c12703 ↗
22. 10.3389/fvets.2019.0019210.3389/fvets.2019.00192 ↗
23. 10.1016/j.bioactmat.2021.03.02210.1016/j.bioactmat.2021.03.022 ↗
24. 10.1002/adma.20230329910.1002/adma.202303299 ↗
25. 10.1002/smll.20220681910.1002/smll.202206819 ↗
26. 10.1016/j.cis.2022.10270510.1016/j.cis.2022.102705 ↗
27. 10.1016/j.carbpol.2023.12093710.1016/j.carbpol.2023.120937 ↗
28. 10.1002/adhm.20230007410.1002/adhm.202300074 ↗
29. 10.1016/j.jconrel.2021.08.06210.1016/j.jconrel.2021.08.062 ↗
30. 10.1016/j.biomaterials.2020.12055510.1016/j.biomaterials.2020.120555 ↗
31. 10.1016/j.actbio.2022.12.05610.1016/j.actbio.2022.12.056 ↗
32. 10.1039/C1SM06513K10.1039/C1SM06513K ↗
33. 10.1093/bioinformatics/btl34510.1093/bioinformatics/btl345 ↗
34. 10.3390/pr1104101410.3390/pr11041014 ↗
35. 10.1038/nmat448910.1038/nmat4489 ↗
36. 10.1039/D1CS00044F10.1039/D1CS00044F ↗
37. 10.1039/D2TB02319A10.1039/D2TB02319A ↗
38. 10.1016/j.mtnano.2021.10016410.1016/j.mtnano.2021.100164 ↗
39. 10.1002/art.4172510.1002/art.41725 ↗
40. 10.1038/s41598-018-27737-y10.1038/s41598-018-27737-y ↗
41. 10.1016/j.bioactmat.2022.02.01610.1016/j.bioactmat.2022.02.016 ↗
42. 10.1002/adma.20200879310.1002/adma.202008793 ↗
43. 10.1016/j.semarthrit.2015.11.00810.1016/j.semarthrit.2015.11.008 ↗
44. Webb D. · Orthop. Res. Rev. · 2018 · 10 · 73
45. 10.1111/1756-185X.1290910.1111/1756-185X.12909 ↗
46. 10.1016/j.joca.2003.09.00710.1016/j.joca.2003.09.007 ↗
47. 10.1016/j.apsb.2019.01.01510.1016/j.apsb.2019.01.015 ↗
48. 10.1002/advs.20210383910.1002/advs.202103839 ↗
49. 10.1021/acsami.2c0912010.1021/acsami.2c09120 ↗
50. 10.1038/s41586-019-0920-110.1038/s41586-019-0920-1 ↗
51. Cho C. · Small · 2022 · 18
52. 10.1016/j.redox.2019.10130610.1016/j.redox.2019.101306 ↗
53. 10.1016/j.joca.2005.07.01410.1016/j.joca.2005.07.014 ↗
54. 10.1016/j.joca.2005.08.01510.1016/j.joca.2005.08.015 ↗
55. 10.1016/j.joca.2005.07.01410.1016/j.joca.2005.07.014 ↗